IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#1046
Positioning
Market Dominance
Services
Healthcare
$1.3B
Christopher J. Reading
U.S. Physical Therapy, Inc. operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. As of December 31, 2021, it operated 591 clinics in 39 states; and managed 35 physical therapy practice facilities. The company was founded in 1990 and is based in Houston, Texas.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = USPH ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$YALA Yalla Group Ltd | 75 | 89 | 99 | 80 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$GRVY GRAVITY Co., Ltd. | 75 | 82 | 96 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ISSC INNOVATIVE SOLUTIONS & SUPPORT INC | 73 | 81 | 88 | 94 | 25.0x | 14.1x | 17.1% | 10.3% | 35.5% | 14.6% | 10.1% | 105.2% | 0.0% | 41.0x | $244M | VS | |
$AER AerCap Holdings N.V. | 72 | 60 | 87 | 84 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$HCSG HEALTHCARE SERVICES GROUP INC | 72 | 74 | 88 | 88 | 7.1x | 6.1x | 28.9% | 20.8% | 20.8% | 9.9% | 9.3% | 8.5% | 0.0% | 1.0x | $1.2B | VS | |
$LQDT LIQUIDITY SERVICES INC | 72 | 90 | 88 | 68 | 24.9x | 14.3x | 14.1% | 8.3% | 45.7% | 8.5% | 6.2% | 28.1% | 0.0% | 0.0x | $736M | VS | |
$TRTNpA Triton International Ltd | 71 | 70 | 89 | 70 | - | 1.7x | 0.0% | - | 97.4% | 58.0% | 37.4% | - | 8.8% | 264.0x | $2.5B | VS | |
$EDU New Oriental Education & Technology Group Inc. | 71 | 83 | 52 | 77 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NTES NetEase, Inc. | 71 | 88 | 93 | 68 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$UTI UNIVERSAL TECHNICAL INSTITUTE INC | 70 | 86 | 86 | 72 | 43.2x | 16.0x | 15.3% | 5.8% | 100.0% | 6.9% | 5.2% | 15.1% | 0.0% | 24.0x | $1.8B | VS | |
$USPH U S PHYSICAL THERAPY INC /NV | 57 | 45 | 57 | 71 | 22.1x | 12.8x | 11.6% | 4.9% | 18.5% | 11.2% | 7.8% | 17.9% | 2.1% | 82.0x | $1.3B | ||
| SECTOR BENCH | - | - | - | - | - | 23.7x | 11.7x | 5.7% | 2.4% | 64.6% | 4.5% | 2.8% | 8.6% | 0.0% | 0.3x | - | REF |
U S PHYSICAL THERAPY INC /NV (USPH) receives a "Hold" rating with a composite score of 56.9/100. It ranks #1046 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
Outperforming peers — winners tend to keep winning over 3-12 months
Fair valuation relative to peers
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Services sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for USPH.
View All Ratings| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 45 | 44 | +1NEUTRAL |
| MOMENTUM | 71 | 80 | -9DRAG |
| VALUATION | 57 | 63 | -6DRAG |
| INVESTMENT | 25 | 14 | +11ALPHA |
| STABILITY | 83 | 91 | -8DRAG |
| SHORT INT | 47 | 45 | +2NEUTRAL |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 15.1% vs WACC 8.8% (spread +6.3%)
GM 19% vs sector 65%, OM 11% vs sector 5%
Capital turnover 1.53x
Rev growth 18%, 10yr history
Interest coverage 10.5x, Net debt/EBITDA 4.2x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate U S PHYSICAL THERAPY INC /NV (USPH) as a Hold with a composite score of 56.9/100 at a current price of $82.95. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling.
U S PHYSICAL THERAPY INC /NV holds a top-quartile position (#0 of 50) within the Services sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 56.9/100 places it at rank #1046 in our full universe.
The near-term outlook is constructive, with revenue growing at 18% and momentum in the 71th percentile confirming positive market sentiment. The combination of strong top-line growth and favorable price dynamics suggests the company is executing well on its growth strategy.
Narrow
Low
Standard
Fair Value
Positive momentum indicates institutional accumulation.
Stable competitive position in a defensive sector.
Vulnerability to macroeconomic shocks and interest rate volatility.
U S PHYSICAL THERAPY INC /NV represents a hold based on multi-factor quantitative performance.
Our model assigns U S PHYSICAL THERAPY INC /NV a Hold rating, with a composite score of 56.9/100 and 3 out of 5 stars. Ranked #1046 of 7,333 stocks, USPH presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 45/100, USPH shows adequate but unremarkable business quality. The company reports a return on equity of 11.6% (sector avg: 5.7%), gross margins of 18.5% (sector avg: 64.6%), net margins of 7.8% (sector avg: 2.8%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
USPH's value score of 57/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 22.07x, an EV/EBITDA of 12.75x, a P/B ratio of 2.56x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
U S PHYSICAL THERAPY INC /NV's investment score of 25/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 17.9% vs. a sector average of 8.6% and a return on assets of 4.9% (sector: 2.4%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
USPH shows strong momentum characteristics with a score of 71/100. The stock has been trending above key moving averages, indicating solid demand from institutional buyers. Revenue growth stands at 17.9% year-over-year, while a beta of 0.77 reflects its sensitivity to broader market moves. This level of momentum typically signals sustained investor confidence and favorable near-term price action.
USPH shows good financial stability with a score of 83/100. Key stability metrics include a beta of 0.77 and a debt-to-equity ratio of 82.00x (sector avg: 0.3x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
The short interest score of 47/100 for USPH suggests somewhat elevated bearish positioning by institutional traders. Specific risk factors include elevated leverage (D/E: 82.00x), small-cap liquidity risk. With a $1.3B market cap (small-cap), U S PHYSICAL THERAPY INC /NV may experience above-average volatility. Investors should consider whether the short thesis has merit or if it creates a potential short-squeeze opportunity.
USPH pays a solid dividend yield of 2.1%, contributing an income component to total returns. This moderate yield suggests a balance between returning capital to shareholders and retaining earnings for reinvestment — a common profile among quality compounders.
U S PHYSICAL THERAPY INC /NV is a small-cap company in the Services sector, ranked #0 of 50 in its sector (100th percentile) and #1046 of 7,333 overall (86th percentile). Key comparisons include ROE of 11.6% exceeding the 5.7% sector median and operating margins of 11.2% above the 4.5% sector average. This top-quartile standing reflects exceptional competitive strength relative to Services peers.
While USPH currently exhibits a HOLD profile, superior opportunities exist within the SERVICES sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Services Alpha →Quant Factor Profile
Key factor gap
Stability (83) vs Investment (25) — closing this gap could shift the rating.
EV/EBITDA 9% ABOVE SECTOR MEDIAN
ROE 102% ABOVE SECTOR MEDIAN (FAVORABLE)
Gross Margin 71% BELOW SECTOR MEDIAN
Above 50MA
37.18%
Net New Highs
+51081
U.S. Physical Therapy Inc. (USPH) announced the acquisition of an industrial injury prevention business for approximately $15.1 million, with the acquired business generating $7.0 million in annual revenues. USPH acquired a 70% interest while the current owner retained 30%. The acquisition expands USPH's industrial injury prevention service offerings.
U.S. Physical Therapy Inc. (USPH) announced the acquisition of a 50% interest in a physical therapy management services company operating eight clinics with approximately $8.0 million in annual revenues and 66,000 annual visits. The current owners retain the remaining 50% stake. USPH operates 780 outpatient physical therapy clinics across 44 states.
U.S. Physical Therapy reported Q2 2025 earnings with mixed results, missing analyst expectations on EPS and revenue, but achieving record patient volumes and strong industrial injury prevention segment growth. The company raised full-year EBITDA guidance and continued its acquisition strategy.
As February begins, U.S. stock markets have shown strong upward momentum with major indices like the Dow Jones and S&P 500 posting significant gains, reflecting investor optimism despite ongoing economic uncertainties such as government shutdowns and trade negotiations. Amidst this backdrop, small-cap stocks in the S&P 600 may present intriguing opportunities for investors seeking value, especially when insider activity suggests potential confidence in these companies' prospects.
U.S. Physical Therapy Inc. (USPH) announced that CEO Chris Reading presented at the J.P. Morgan 2026 Healthcare Conference on January 14, 2026. The company operates 780 outpatient physical therapy clinics across 44 states and provides industrial injury prevention services.